Eltromag 25 Tablet
Marketer
Cipla Ltd
Salt Composition
Eltrombopag (25mg)
Overview Eltromag 25 Tablet
Trombopoietin-receptor agonist Eltromag 25mg tablets are indicated for managing thrombocytopenia stemming from chronic immune thrombocytopenic purpura (ITP) or chronic hepatitis C (HCV). This medication also addresses severe aplastic anemia. Its mechanism involves stimulating platelet production, thereby mitigating bleeding risk. Adhere strictly to your physician's prescribed dosage and duration; it can be taken on an empty stomach. Swallow the tablet whole; avoid crushing, chewing, or breaking. Report any known allergies to this medication. Common adverse effects encompass nausea, vomiting, diarrhea, upper respiratory infections, and urinary tract infections. Consult your doctor regarding persistent or bothersome side effects; management strategies may be available. Prior to commencing treatment, disclose any existing medical conditions or concurrent medications. Patients with liver impairment may require dosage modification; inform your doctor accordingly.
Uses of Eltromag 25 Tablet
Thrombocytopenia from immune thrombocytopenic purpura or hepatitis C; Management of critical bone marrow failure
Major Benefits of Eltromag 25 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Eltromag 25 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Eltromag 25 Tablet:
- Nausea
- Diarrhea
- Upper respiratory tract infection
- Vomiting
- Increased liver enzymes
- Muscle pain
- Urinary tract infection
How to use Eltromag 25 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Eltromag 25 Tablet on an empty stomach.
How Eltromag 25 Tablet works:
Eltrombopag 25 mg tablets stimulate platelet production. This thrombopoietin receptor agonist increases blood platelet count, thereby lessening the risk of bleeding.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of alcohol consumption while taking Eltromag 25 Tablet is undetermined. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
Use of Eltromag 25 Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Eltromag 25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Eltromag 25 Tablet side effects. Dizziness and reduced alertness, potential side effects of Eltromag 25 Tablet, can negatively impact driving skills.
KidneySAFE IF PRESCRIBED
Eltromag 25 Tablet is considered safe for individuals with kidney impairment; dosage modification isn't typically necessary. Nevertheless, disclosure of any kidney condition to your physician is recommended. Routine monitoring of kidney function is advisable during treatment with this medication.
LiverCAUTION
Patients with liver impairment should use Eltromag 25 mg tablets cautiously, as dose modification may be necessary. Physician consultation is advised.
What if you forget to take Eltromag 25 Tablet :
Omit any missed Eltromag 25 Tablet dose and resume your regular medication regimen. Avoid taking a double dose.
Facts to Know About Eltromag 25 Tablet
| Label | Value |
|---|---|
| Chemical Category | Biphenyl Derivatives |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Action Category | Thrombopoietin receptor activator |

